In regard to clinical studies, Clària et al30 have demonstrated dysregulation of the KP in patients with decompensated cirrhosis and acute-on-chronic liver failure, where high baseline KP activity was able to predict clinical course and mortality. The gene discussed is NPPA; the disease is Cirrhosis.